ClearPoint Neuro, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ClearPoint Neuro, Inc. (CLPT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$3.13 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-11
- ClearPoint Neuro, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$678.00.
- ClearPoint Neuro, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $0.00.
- ClearPoint Neuro, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$22.68K.
- ClearPoint Neuro, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was -$77.65K.
- ClearPoint Neuro, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$101.00K.
- ClearPoint Neuro, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$76.88K.
- ClearPoint Neuro, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$48.13K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$3.13K 10-Q · filed 2017-08-11 | |||
| 2016-12-31 | -$678.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$678.00 derived: sum of 2 quarters · filed 2017-03-09 | -$23.35K derived: sum of 3 quarters · filed 2017-08-11 | -$101.00K 10-K · filed 2017-03-09 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$22.68K derived: sum of 2 quarters · filed 2017-08-11 | -$100.32K 10-Q · filed 2016-11-09 | -$105.19K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-06-30 | -$22.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$100.32K 10-Q · filed 2017-08-11 | -$105.19K derived: sum of 3 quarters · filed 2017-08-11 | -$169.83K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | -$77.65K 10-Q · filed 2017-05-09 | -$82.51K derived: sum of 2 quarters · filed 2017-05-09 | -$147.16K derived: sum of 3 quarters · filed 2017-05-09 | -$147.90K derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | -$4.86K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$69.51K derived: sum of 2 quarters · filed 2017-03-09 | -$70.25K derived: sum of 3 quarters · filed 2017-03-09 | -$76.88K 10-K · filed 2017-03-09 |
| 2015-09-30 | -$64.64K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | -$65.39K derived: sum of 2 quarters · filed 2016-11-09 | -$72.02K 10-Q · filed 2016-11-09 | -$108.56K derived: sum of 4 quarters · filed 2016-11-09 |
| 2015-06-30 | -$742.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2016-09-21 | -$7.38K 10-Q/A · filed 2016-09-21 | -$43.92K derived: sum of 3 quarters · filed 2016-09-21 | -$50.13K derived: sum of 4 quarters · filed 2016-09-21 |
| 2015-03-31 | -$6.63K 10-Q · filed 2016-05-06 | -$43.17K derived: sum of 2 quarters · filed 2016-05-06 | -$49.39K derived: sum of 3 quarters · filed 2016-05-06 | |
| 2014-12-31 | -$36.54K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$42.75K derived: sum of 2 quarters · filed 2016-03-25 | -$48.13K 10-K · filed 2016-03-25 | |
| 2014-09-30 | -$6.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$11.59K 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | -$5.38K 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |